BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11392060)

  • 1. Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis.
    Cavaletti G; Perseghin P; Buscemi F; Dassi M; Oggioni N; Sala F; Lolli F; Liuzzi GM; Riccio P; Frattola L; Tredici G
    Int J Tissue React; 2001; 23(1):21-31. PubMed ID: 11392060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells.
    Cavaletti G; Perseghin P; Dassi M; Oggioni N; Sala F; Braga M; Lolli F; Riccio P; Carlone G; Zoia C; Tagliabue E; Stanzani L; Galbiati S; Rigamonti L; Marmiroli P; Ferrarese C; Frattola L; Tredici G
    J Biol Regul Homeost Agents; 2004; 18(1):9-17. PubMed ID: 15323355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats.
    Chelmicka-Schorr E; Wiegmann K; Wollmann R; Arnason BG; Kim DH
    J Autoimmun; 1998 Aug; 11(4):329-34. PubMed ID: 9776710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photopheresis affects the course of experimental allergic encephalomyelitis in Lewis rat.
    Chabannes D; Besnier DP; Esnault VL
    Photodermatol Photoimmunol Photomed; 2002 Oct; 18(5):238-43. PubMed ID: 12390665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F
    Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prazosin treatment during the effector stage of disease suppresses experimental autoimmune encephalomyelitis in the Lewis rat.
    Brosnan CF; Sacks HJ; Goldschmidt RC; Goldmuntz EA; Norton WT
    J Immunol; 1986 Dec; 137(11):3451-6. PubMed ID: 3491136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells.
    Donia M; Mangano K; Amoroso A; Mazzarino MC; Imbesi R; Castrogiovanni P; Coco M; Meroni P; Nicoletti F
    J Autoimmun; 2009 Sep; 33(2):135-40. PubMed ID: 19625166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis.
    Pettersson A; Ciumas C; Chirsky V; Link H; Huang YM; Xiao BG
    J Neuroimmunol; 2004 Nov; 156(1-2):58-65. PubMed ID: 15465596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
    de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
    J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
    J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enkephalins and autoimmunity: differential effect of methionine-enkephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats.
    Janković BD; Marić D
    J Neurosci Res; 1987; 18(1):88-94. PubMed ID: 3500326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
    Beyersdorf N; Gaupp S; Balbach K; Schmidt J; Toyka KV; Lin CH; Hanke T; Hünig T; Kerkau T; Gold R
    J Exp Med; 2005 Aug; 202(3):445-55. PubMed ID: 16061730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of GSM-900 microwaves on the experimental allergic encephalomyelitis (EAE) rat model of multiple sclerosis.
    Anane R; Geffard M; Taxile M; Bodet D; Billaudel B; Dulou PE; Veyret B
    Bioelectromagnetics; 2003 Apr; 24(3):211-3. PubMed ID: 12669305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of acute and relapsing stages of the experimental allergic encephalomyelitis by cobra toxins.
    Mohamed A; Reid PF; Raymond L; Dufan T
    Biomed Sci Instrum; 2006; 42():399-404. PubMed ID: 16817641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
    Ji Q; Goverman J
    Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of digital technology to asses the severity of the Experimental Allergic Encephalomyelitis (EAE) spinal cord lesion.
    Mohamed A; Tarhuni H; Dufan T; Benghuzzi H; Tucci M
    Biomed Sci Instrum; 2004; 40():419-23. PubMed ID: 15133994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
    Tutaj M; Szczepanik M
    J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis.
    Foster CA; Howard LM; Schweitzer A; Persohn E; Hiestand PC; Balatoni B; Reuschel R; Beerli C; Schwartz M; Billich A
    J Pharmacol Exp Ther; 2007 Nov; 323(2):469-75. PubMed ID: 17682127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.